The full value of mRNA seasonal influenza and endemic-stage COVID-19 combination vaccines: a taxonomy
Many value elements in the taxonomy are traditional narrow values and fit within a health payer perspective, but the taxonomy also captures broader societal values. This taxonomy can support more comprehensive valuations of mRNA combo vaccines in national vaccine recommendation and funding decisions.
Authors
- Tianyan Hu (ORCID: https://orcid.org/0000-0003-4886-1902)
- Daria Burnes (ORCID: https://orcid.org/0000-0002-8624-1344)
- Genevieve Meier (ORCID: https://orcid.org/0000-0003-1228-6969)
- Jangsik Yang
- Joseph S Knee (ORCID: https://orcid.org/0000-0001-5300-4206)
- Manuela Di Fusco
- David E. Bloom
- J. P. Sevilla
Institutions
- Harvard University (US)
- Pfizer (United States) (US)
- Health Decisions (United States) (US)
- Renesas Electronics (United States) (US)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2026-03-17
- DOI
- https://doi.org/10.1080/13696998.2026.2638676
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00